These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1634923)
21. Temporary shielding of hot spots in the drainage areas of cutaneous melanoma improves accuracy of lymphoscintigraphic sentinel lymph node diagnostics. Maza S; Valencia R; Geworski L; Zander A; Dräger E; Winter H; Sterry W; Munz DL Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1399-402. PubMed ID: 12271426 [TBL] [Abstract][Full Text] [Related]
22. [Initial experiences with a new monoclonal antibody in diagnosis of malignant melanomas]. Omlor G; Berberich R; Gross G; Alexander C; Feifel G Langenbecks Arch Chir; 1991; 376(6):359-62. PubMed ID: 1775002 [TBL] [Abstract][Full Text] [Related]
24. Radioimmunoscintigraphy in patients with ocular melanoma. Sergieva SB; Virtcheva-Genkova A Clin Nucl Med; 1997 Jan; 22(1):25-9. PubMed ID: 8993869 [TBL] [Abstract][Full Text] [Related]
25. Detection and staging of small cell lung carcinoma with a technetium-labeled monoclonal antibody. A comparison with standard staging methods. Balaban EP; Walker BS; Cox JV; Bordlee RP; Salk D; Abrams PG; Sheehan RG; Frenkel EP Clin Nucl Med; 1992 Jun; 17(6):439-45. PubMed ID: 1319861 [TBL] [Abstract][Full Text] [Related]
26. Imaging of colorectal carcinoma with technetium-99m radiolabeled Fab' fragments. Podoloff DA; Patt YZ; Curley SA; Kim EE; Bhadkamkar VA; Smith RE Semin Nucl Med; 1993 Apr; 23(2):89-98. PubMed ID: 8511605 [TBL] [Abstract][Full Text] [Related]
27. Immunoscintigraphy in malignant melanoma: a five-year clinical experience. Feggi L; Indelli M; Pansini GC; Santini A; Prandini N; Virgili AR Nucl Med Commun; 1993 Feb; 14(2):145-8. PubMed ID: 8429994 [TBL] [Abstract][Full Text] [Related]
28. Role of radioimmunoscintigraphy and SPET in the diagnosis of patients with malignant melanoma. Sergieva S; Goranov K; Piperkova E; Tzingilev D; Trojanova P; Peitcheva E; Kulkin V Nucl Med Commun; 1994 Mar; 15(3):168-72. PubMed ID: 8190407 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET. Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889 [TBL] [Abstract][Full Text] [Related]
30. The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making. Gulec SA; Faries MB; Lee CC; Kirgan D; Glass C; Morton DL; Essner R Clin Nucl Med; 2003 Dec; 28(12):961-5. PubMed ID: 14663316 [TBL] [Abstract][Full Text] [Related]
32. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound. Ji T; Sun Y; Chen B; Ji B; Gao S; Ma Q; Cheng G; Zhang H Hell J Nucl Med; 2015; 18(2):108-13. PubMed ID: 26187209 [TBL] [Abstract][Full Text] [Related]
33. Correlation between Breslow thickness and Technetium-99m-sestamibi uptake in cutaneous melanoma. Masiero N; Costa MM; Masiero PR; Rosa L; Bakos R; Cartell A; Migliavacca A; Bakos L Eur J Dermatol; 2013; 23(4):467-70. PubMed ID: 23816542 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of metastatic melanoma with planar and SPECT scintigraphy using ZME 018 and 96.5 radiolabeled monoclonal antibodies. Jaffe RM; Alderson PO; Seldin DW; Esser PD; Bartholomew RM; Hyman GA Cancer Detect Prev; 1988; 12(1-6):303-12. PubMed ID: 3263197 [TBL] [Abstract][Full Text] [Related]
35. Decisive role of SPECT/CT in localization of unusual periscapular sentinel nodes in patients with posterior trunk melanoma: three illustrative cases and a review of the literature. Alvarez Paez AM; Brouwer OR; Veenstra HJ; van der Hage JA; Wouters M; Nieweg OE; Valdés-Olmos RA Melanoma Res; 2012 Jun; 22(3):278-83. PubMed ID: 22456165 [TBL] [Abstract][Full Text] [Related]
36. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer. de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020 [TBL] [Abstract][Full Text] [Related]